ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Skinbiotherapeutics Plc

Skinbiotherapeutics Plc (SBTX)

10,25
-0,25
(-2,38%)
Geschlossen 11 Juli 5:30PM

Skinbiotherapeutics Plc (SBTX) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
10,25
( -2,38% )
Gebot
10,00
Fragen
10,50
Volumen
7.777
Durchschnittliches Volumen (3 Mio.)
1.008.226p
Finanzvolumen
-
10,25 Tagesbereich 10,50
5,20 52-Wochen-Bereich 22,50
Marktkapitalisierung
Unternehmenswert
25,027M
Handelsende
10,50
Handelsbeginn
10,50
Letzte Trade
40
@
10.0025
(O)
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
5,23M
Nettogewinn (LTM)
-456,41k
Ausgegebene Aktien
259.168.671
Streubesitz (%)
55,40%
Institutioneller Besitz (%)
59,68%
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-56,54
Kurs-Umsatz-Verhältnis (KUV)
5,21
Gewinn pro Aktie (EPS)
-0
Beta
0,11

Über Skinbiotherapeutics Plc

SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome ... SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with Croda Plc for the development of SkinBiotix as an active ingredient for the skicare and cosmetic industry. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom. Mehr anzeigen

Sektor
Health Care
Branche
-
Hauptsitz
Newcastle Upon Tyne, United Kingdom
Gegründet
2026
Skinbiotherapeutics Plc is listed in the Health Care sector of the Londoner Börse with ticker SBTX. The last closing price for Skinbiotherapeutics was 10,50p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 5,20p to 22,50p.

Skinbiotherapeutics currently has 259.168.671 shares in issue. The market capitalisation of Skinbiotherapeutics is £26,56 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -56.54.

SBTX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.25-2.3809523809510.510.510.258063410.5DE
43.7557.69230769236.513.256.575889210.70469416DE
122.2528.125813.256.258939039.97839779DE
26-11.25-52.325581395321.522.55.2379697810.43639512DE
52-6.5-38.805970149316.7522.55.2206743011.84927683DE
156-1.875-15.463917525812.12529.55.2125635613.93302366DE
260-51.75-83.46774193556277.55.291844418.36777793DE

SBTX - Frequently Asked Questions (FAQ)

What is the current Skinbiotherapeutics Plc share price?
The current share price of Skinbiotherapeutics Plc is 10,25p
How many Skinbiotherapeutics Plc shares are in issue?
Skinbiotherapeutics Plc has 259.168.671 shares in issue
What is the market cap of Skinbiotherapeutics Plc?
The market capitalisation of Skinbiotherapeutics Plc is GBP 26,56M
What is the 1 year trading range for Skinbiotherapeutics Plc share price?
Skinbiotherapeutics Plc has traded in the range of 5,20p to 22,50p during the past year
What is the PE ratio of Skinbiotherapeutics Plc?
The price to earnings ratio of Skinbiotherapeutics Plc is -56,54
What is the cash to sales ratio of Skinbiotherapeutics Plc?
The cash to sales ratio of Skinbiotherapeutics Plc is 5,21
What is the registered address of Skinbiotherapeutics Plc?
The registered address for Skinbiotherapeutics Plc is The Core, Newcastle upon Tyne, Tyne and Wear, NE4 5TF
What is the Skinbiotherapeutics Plc website address?
The website address for Skinbiotherapeutics Plc is www.skinbiotherapeutics.com

SBTX Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen